OpGen, Inc. (OTC:OPGN – Get Free Report)’s share price crossed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of $0.73 and traded as high as $5.03. OpGen shares last traded at $4.95, with a volume of 2,624 shares trading hands.
OpGen Price Performance
The firm has a market cap of $49.85 million, a P/E ratio of -0.89 and a beta of -1.77. The stock’s 50 day moving average is $0.73 and its two-hundred day moving average is $3.05.
OpGen Company Profile
OpGen, Inc, a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis CE-IVD-marked polymerase chain reaction-based SARS-CoV-2 test kits.
Recommended Stories
- Five stocks we like better than OpGen
- What Do S&P 500 Stocks Tell Investors About the Market?
- 3 Beaten-Down Stocks With Rebound Potential This Earnings Season
- 3 Warren Buffett Stocks to Buy Now
- Amazon Is One of the Clearest Buys If the Market Dips Again
- How to find penny stocks to invest and trade
- CoreWeave’s Guidance Cut: A Buying Opportunity in Disguise?
Receive News & Ratings for OpGen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OpGen and related companies with MarketBeat.com's FREE daily email newsletter.
